Corticosteroid switch from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone.

BMC Cancer · 2021 · PMC8364094 · PMID 34388965

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Furthermore, LDH, Hb and ALP were not included in univariate and multivariate analyses due to lack of data, which may be significant prognostic factors; and only patients with ECOG≤2 were included, this could have impact on OS.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.